GINA KOONS: Open Payments
NPI 1013493105 · HARRISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,928 in 173 payments from 32 companies in 2025. Trend: 2023 $2,471 · 2024 $2,559 · 2025 $2,928
Food & beverage: $2,928
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $554 |
| Novo Nordisk Inc | 20 | $290 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $204 |
| AstraZeneca Pharmaceuticals LP | 6 | $179 |
| Lilly USA, LLC | 9 | $176 |
| PFIZER INC. | 19 | $160 |
| Amgen Inc. | 15 | $135 |
| GlaxoSmithKline, LLC. | 6 | $116 |
| Exact Sciences Corporation | 4 | $102 |
| Axsome Therapeutics, Inc. | 4 | $82 |
Products named: UBRELVY, JARDIANCE, VRAYLAR, ELIQUIS, Wegovy, Ozempic, MOUNJARO, QULIPTA.
Industry payments across PA — which companies pay providers there.
